Community 365 Roundtable Meeting: 2023 - A Year of Opportunities on Pharmaceutical Access and Value

We're pleased to invite you to the Community 365 Roundtable Meeting: 2023 - Year of Opportunities on Pharmaceutical Access and Value which aims to address the upcoming revisions to the EU Pharmaceutical Regulations and what it means for cancer, as well as discuss the application of the EU's HTA Regulation and its relevance to cancer.

Join Co-Chairs Matti Aapro, ECO Immediate Past-President, and Mirjam Crul, ECO Board Member and Co-Chair of both our Special Network on the Impact of Covid-19 on Cancer and our Workforce Network, on 27 February from 16:00-18:30 CET.

27 February 2023 16:00 - 18:30 CET

Virtual

Apply for Registration

This is an Inequalities Network related event and also supported by our National & European Parliamentarians for Cancer Action group:

ineqv2 Parliamentarians for Cancer Action Logo.1


Programme


1600-1610: Welcome and introductions

  • Matti Aapro, Immediate Past-President, European Cancer Organisation
16:10-17:00: Part 1 - The Upcoming Revisions to the EU Pharmaceutical Regulations and What it Means for Cancer

16:10-16:25 - Current Status of the Pharmaceutical Regulations update & Providing Relevant Background

16:25-16:55: Unmet Medical Need - How to Better Define? How Might the Cancer Sector Benefit?

  • Kostas Stamatopoulos, Member, Research and European Affairs Committees, European Hematology Association

16:55-17:00: Summary and Conclusions from the Discussion


17:00-17:40: Part 2 - The Opportunities for Addressing Medicines Shortages in 2023

17:00-17:15: Setting the Scene - The Shortages Situation We Face

17:15-17:25: The EMA’s New Role on Medicines Shortages

17:25-17:35: Exchange on Next Steps

  • Despoina Makridaki, Director of Professional Development, European Association of Hospital Pharmacists (EAHP) 
17:35-17:40: Summary and Conclusions from the Discussion


17:40-18:20: Part 3 - The Application of the EU’s HTA Regulation and its Relevance to Cancer 

17:40-17:55: What is the EU HTA Regulation? What Does it Mean for Cancer? 

  • Dirk Van den Steen, Deputy Head of Unit, State of Health, European Semester, Health Technology Assessment (SANTE.C.2)  
17:55-18:05: How is the Progress of the Regulation so far? What’s Upcoming?

18:05-18:20: Exchange and Discussion on the HTA Regulation and What it Means for Cancer 

  • Robin Doeswijk, Head of European Affairs, European Hematology Association

18:20-18:30: Part 4 - Conclusions

Speakers

  • Tomislav Sokol MEP MEMBER, SPECIAL COMMITTEE ON THE COVID-19 PANDEMIC (COVI), and Member, Parliamentarians for Cancer Action, Croatia
  • Sara Cerdas MEP Member, Special Committee on the Covid-19 Pandemic (COVI), and Member, Parliamentarians for Cancer Action, Portugal
  • Matti Aapro Immediate Past-President, European Cancer Organisation
  • Mirjam Crul Board Member and Co-Chair of both the Special Network on the Impact of Covid-19 on Cancer and Workforce Network, European Cancer Organisation
  • Dirk Van den Steen Deputy Head of Unit, State of Health, European Semester, Health Technology Assessment (SANTE.C.2)
  • Kostas Stamatopoulos Member, Research and European Affairs Committees, European Hematology Association

Speakers

  • Tomislav Sokol MEP MEMBER, SPECIAL COMMITTEE ON THE COVID-19 PANDEMIC (COVI), and Member, Parliamentarians for Cancer Action, Croatia
  • Sara Cerdas MEP Member, Special Committee on the Covid-19 Pandemic (COVI), and Member, Parliamentarians for Cancer Action, Portugal
  • Matti Aapro Immediate Past-President, European Cancer Organisation
  • Mirjam Crul Board Member and Co-Chair of both the Special Network on the Impact of Covid-19 on Cancer and Workforce Network, European Cancer Organisation
  • Dirk Van den Steen Deputy Head of Unit, State of Health, European Semester, Health Technology Assessment (SANTE.C.2)
  • Kostas Stamatopoulos Member, Research and European Affairs Committees, European Hematology Association
  • Tomislav Sokol MEP MEMBER, SPECIAL COMMITTEE ON THE COVID-19 PANDEMIC (COVI), and Member, Parliamentarians for Cancer Action, Croatia Read Bio
  • Sara Cerdas MEP Member, Special Committee on the Covid-19 Pandemic (COVI), and Member, Parliamentarians for Cancer Action, Portugal Read Bio
  • Matti Aapro Immediate Past-President, European Cancer Organisation
  • Mirjam Crul Board Member and Co-Chair of both the Special Network on the Impact of Covid-19 on Cancer and Workforce Network, European Cancer Organisation
  • Dirk Van den Steen Deputy Head of Unit, State of Health, European Semester, Health Technology Assessment (SANTE.C.2) Read Bio
  • Kostas Stamatopoulos Member, Research and European Affairs Committees, European Hematology Association Read Bio
  • Despoina Makridaki Director, Professional Development, European Association of Hospital Pharmacists (EAHP) Read Bio

Speakers

  • Tomislav Sokol MEP MEMBER, SPECIAL COMMITTEE ON THE COVID-19 PANDEMIC (COVI), and Member, Parliamentarians for Cancer Action, Croatia
  • Sara Cerdas MEP Member, Special Committee on the Covid-19 Pandemic (COVI), and Member, Parliamentarians for Cancer Action, Portugal
  • Matti Aapro Immediate Past-President, European Cancer Organisation
  • Mirjam Crul Board Member and Co-Chair of both the Special Network on the Impact of Covid-19 on Cancer and Workforce Network, European Cancer Organisation
  • Dirk Van den Steen Deputy Head of Unit, State of Health, European Semester, Health Technology Assessment (SANTE.C.2)
  • Kostas Stamatopoulos Member, Research and European Affairs Committees, European Hematology Association

Speakers

  • Tomislav Sokol MEP MEMBER, SPECIAL COMMITTEE ON THE COVID-19 PANDEMIC (COVI), and Member, Parliamentarians for Cancer Action, Croatia
  • Sara Cerdas MEP Member, Special Committee on the Covid-19 Pandemic (COVI), and Member, Parliamentarians for Cancer Action, Portugal
  • Matti Aapro Immediate Past-President, European Cancer Organisation
  • Mirjam Crul Board Member and Co-Chair of both the Special Network on the Impact of Covid-19 on Cancer and Workforce Network, European Cancer Organisation
  • Dirk Van den Steen Deputy Head of Unit, State of Health, European Semester, Health Technology Assessment (SANTE.C.2)
  • Kostas Stamatopoulos Member, Research and European Affairs Committees, European Hematology Association